Cargando…
High alert drugs screening using gradient boosting classifier
Prescription errors in high alert drugs (HAD), a group of drugs that have a high risk of complications and potential negative consequences, are a major and serious problem in medicine. Standardized hospital interventions, protocols, or guidelines were implemented to reduce the errors but were not fo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505501/ https://www.ncbi.nlm.nih.gov/pubmed/34635694 http://dx.doi.org/10.1038/s41598-021-99505-4 |
_version_ | 1784581546837016576 |
---|---|
author | Wongyikul, Pakpoom Thongyot, Nuttamon Tantrakoolcharoen, Pannika Seephueng, Pusit Khumrin, Piyapong |
author_facet | Wongyikul, Pakpoom Thongyot, Nuttamon Tantrakoolcharoen, Pannika Seephueng, Pusit Khumrin, Piyapong |
author_sort | Wongyikul, Pakpoom |
collection | PubMed |
description | Prescription errors in high alert drugs (HAD), a group of drugs that have a high risk of complications and potential negative consequences, are a major and serious problem in medicine. Standardized hospital interventions, protocols, or guidelines were implemented to reduce the errors but were not found to be highly effective. Machine learning driven clinical decision support systems (CDSS) show a potential solution to address this problem. We developed a HAD screening protocol with a machine learning model using Gradient Boosting Classifier and screening parameters to identify the events of HAD prescription errors from the drug prescriptions of out and inpatients at Maharaj Nakhon Chiang Mai hospital in 2018. The machine learning algorithm was able to screen drug prescription events with a risk of HAD inappropriate use and identify over 98% of actual HAD mismatches in the test set and 99% in the evaluation set. This study demonstrates that machine learning plays an important role and has potential benefit to screen and reduce errors in HAD prescriptions. |
format | Online Article Text |
id | pubmed-8505501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85055012021-10-13 High alert drugs screening using gradient boosting classifier Wongyikul, Pakpoom Thongyot, Nuttamon Tantrakoolcharoen, Pannika Seephueng, Pusit Khumrin, Piyapong Sci Rep Article Prescription errors in high alert drugs (HAD), a group of drugs that have a high risk of complications and potential negative consequences, are a major and serious problem in medicine. Standardized hospital interventions, protocols, or guidelines were implemented to reduce the errors but were not found to be highly effective. Machine learning driven clinical decision support systems (CDSS) show a potential solution to address this problem. We developed a HAD screening protocol with a machine learning model using Gradient Boosting Classifier and screening parameters to identify the events of HAD prescription errors from the drug prescriptions of out and inpatients at Maharaj Nakhon Chiang Mai hospital in 2018. The machine learning algorithm was able to screen drug prescription events with a risk of HAD inappropriate use and identify over 98% of actual HAD mismatches in the test set and 99% in the evaluation set. This study demonstrates that machine learning plays an important role and has potential benefit to screen and reduce errors in HAD prescriptions. Nature Publishing Group UK 2021-10-11 /pmc/articles/PMC8505501/ /pubmed/34635694 http://dx.doi.org/10.1038/s41598-021-99505-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wongyikul, Pakpoom Thongyot, Nuttamon Tantrakoolcharoen, Pannika Seephueng, Pusit Khumrin, Piyapong High alert drugs screening using gradient boosting classifier |
title | High alert drugs screening using gradient boosting classifier |
title_full | High alert drugs screening using gradient boosting classifier |
title_fullStr | High alert drugs screening using gradient boosting classifier |
title_full_unstemmed | High alert drugs screening using gradient boosting classifier |
title_short | High alert drugs screening using gradient boosting classifier |
title_sort | high alert drugs screening using gradient boosting classifier |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505501/ https://www.ncbi.nlm.nih.gov/pubmed/34635694 http://dx.doi.org/10.1038/s41598-021-99505-4 |
work_keys_str_mv | AT wongyikulpakpoom highalertdrugsscreeningusinggradientboostingclassifier AT thongyotnuttamon highalertdrugsscreeningusinggradientboostingclassifier AT tantrakoolcharoenpannika highalertdrugsscreeningusinggradientboostingclassifier AT seephuengpusit highalertdrugsscreeningusinggradientboostingclassifier AT khumrinpiyapong highalertdrugsscreeningusinggradientboostingclassifier |